Cannabidiol: Clinical Trials

14 trials of Cannabidiol, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 2 not yet recruiting, 1 active not recruiting, 1 recruiting. 14 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 414Completed 7, Not yet recruiting 2, Active not recruiting 1, Recruiting 1, Terminated 1, Unknown 1, Withdrawn 1

Follow Cannabidiol: new trials by email Literature Review of Cannabidiol trials Research Report on Cannabidiol

Trials (filtered) newest first · largest first

All 14 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Investigate the Transition of Children From 'Artisanal" Cannabidiol (CBD) to Epidiolex
Epidiolex 100 mg/mL Oral Solution - Dravet Syndrome (DS), Lennox-Gastaut Syndrome (LGS)
Phase 4Not yet recruitingElizabeth Donner252027-01-012026-09-11
A Study to Investigate the Effect of Gradual Titration to Optimize Cannabidiol Treatment in Adults With LGS
Cannabidiol Oral Solution - Lennox-Gastaut Syndrome
Phase 4Not yet recruitingJazz Pharmaceuticals402026-11-182026-11-17
Investigating the Effects of Cannabidiol on Social Anxiety Disorder
Cannabidiol, Placebo - Phobia, Social
Phase 4RecruitingMassachusetts Institute of Technology502025-07-102026-08-11
A Study to Investigate Behavioral and Other Co-Occurring Outcomes With Epidiolex as Add-On Therapy in Participants Aged 1 to 65 Years of Age With Tuberous Sclerosis Complex
Cannabidiol Oral Solution [Epidiolex] - Tuberous Sclerosis Complex Associated Neuropsychiatric Disease
Phase 4CompletedJazz Pharmaceuticals792023-06-292026-04-27
Cannabidiol for Bilateral Total Knee Arthroplasty
cannabidiol, Ora-sweet SF - Pain, Postoperative, Opioid Use
Phase 4CompletedHospital for Special Surgery, New York372022-11-022026-05-26
Single-cell CBD Biomarkers of Inflammation Reduction in People Living With HIV
CBD oil - Chronic Inflammation
Phase 4CompletedUniversity of Florida42022-05-012023-12-28
Epidiolex® for Anxiety in Pediatric Epilepsy
Cannabidiol 100 MG/ML - Anxiety, Epilepsy
Phase 4CompletedHugo W. Moser Research Institute at Kennedy Krieger, Inc.202022-04-052025-07-02
Epidiolex in Typical Absence Seizures
Cannabidiol (Epidiolex) - Study the Efficacy of Epidiolex for Typical Absence Seizures
Phase 4CompletedUniversity of South Florida142021-07-302023-07-11
Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution
Cannabidiol - Lennox Gastaut Syndrome, Dravet Syndrome
Phase 4Active not recruitingJazz Pharmaceuticals1542021-07-072026-08-26
The Effects of Cannabidiol and Homotaurine in Patients With Mild Cognitive Impairment
Cannabidiol Oil, Homotaurine - Mild Cognitive Impairment
Phase 4UnknownAristotle University Of Thessaloniki902021-04-012021-08-26
Cannabidiol and CES1 Interactions in Healthy Subjects
dl-Methylphenidate plus Cannabidiol, dl-Methylphenidate plus Cannabidiol Placebo solution - Drug Interaction
Phase 4CompletedUniversity of Florida142021-02-252024-07-18
Investigation of Cognitive Outcomes With Cannabidiol Oral Solution
GWP42003-P - Lennox-Gastaut Syndrome
Phase 4WithdrawnJazz Pharmaceuticals2020-10-012022-09-01
Cannabidiol and Oral Contraceptive Pills: Exploring a Drug-Drug Interaction
Cannabidiol Oil, Placebo, Combined oral contraceptive pill - Contraception
Phase 4CompletedOregon Health and Science University92020-04-082023-07-11
Investigation of Cannabidiol for Reduction of NeuroInflammation in Chronic Back Pain
Cannabidiol - Back Pain, Low
Phase 4TerminatedMassachusetts General Hospital72019-11-132022-05-04

Conditions studied

Lennox Gastaut Syndrome (4)  ·  Epilepsies, Myoclonic (2)  ·  Epilepsy (2)  ·  Seizures (2)  ·  Tuberous Sclerosis (2)  ·  Anxiety Disorders (1)  ·  Behavior (1)  ·  Cognitive Dysfunction (1)  ·  Liver Cirrhosis (1)  ·  Low Back Pain (1)  ·  Osteoarthritis, Knee (1)  ·  Pain, Postoperative (1)  ·  Phobia, Social (1)  ·  Psychological Well-Being (1)

Sponsors

Jazz Pharmaceuticals (4)  ·  University of Florida (2)  ·  Aristotle University Of Thessaloniki (1)  ·  Elizabeth Donner (1)  ·  Hospital for Special Surgery, New York (1)  ·  Hugo W. Moser Research Institute at Kennedy Krieger, Inc. (1)  ·  Massachusetts General Hospital (1)  ·  Massachusetts Institute of Technology (1)  ·  Oregon Health and Science University (1)  ·  University of South Florida (1)

Countries

United States (11)  ·  Canada (2)  ·  Greece (1)  ·  Poland (1)  ·  United Kingdom (1)

Top investigators

Alexandra Sideris, PhD (1)  ·  Elizabeth Donner, MD (1)  ·  Jay Salpekar (1)  ·  Jodi Gilman, PhD (1)  ·  John Gabrieli, PhD (1)  ·  John Markowitz, Pharm.D (1)  ·  Shaalini Ramanadhan, MD (1)  ·  Simone Marini, PhD (1)

Results publications

PMID 38252549, PMID 42435131

NIH funding

2023 (1)